ASCI / Young Physician-Scientist Awards, 2023

As a clinical researcher and interventional cardiologist, Jennifer Rymer, MD, MBA plans to devote her career to improving the care and outcomes of patients with peripheral arterial disease (PAD) and acute coronary syndromes (ACS). Dr. Rymer cares for patients at Duke and at a community hospital with poor access to care who present with advanced PAD and are at high risk of limb loss. Much of her clinical work is focused on limb salvage, and this clinical work has become the basis for her research. Dr. Rymer received an American Heart Association Career Development Award to develop an instrument that assists the clinician with prescribing appropriate guideline-directed medical therapy (GDMT) for patients with PAD and assessing barriers to adherence to GDMT. Additionally, she was awarded the Women As One Research Award for my work in validating patient-reported outcomes in patients with advanced PAD and in African American patients with PAD. For this work, she was recently honored with the Linnemeier Award, one of the top early career investigator awards given to an academic interventional cardiologist by the Cardiovascular Research Foundation. Dr. Rymer is passionate about mentoring trainees interested in pursuing a career in clinical research. She is currently the PI of a program sponsored by Pfizer to engage underrepresented minority college students in clinical research training to foster a more diverse workforce in clinical research. Dr. Rymer was awarded by the Duke Medicine Residency with the 2022 research mentor of the year for my devotion to mentorship. She also enjoys her roles as national PI on a 12-site registry of cangrelor use in patients with myocardial infarction (MI) which has enrolled 3,000 patients; and as a co-investigator on the SOS-AMI trial of selatogrel use in post-MI patients. Finally, Dr. Rymer is the data coordinating center PI for the NCDR CathPCI and Chest Pain MI Registries at the DCRI.